Open access peer-reviewed chapter

Future Aspects of Prostate Biopsy – The Use of Primary Circulating Prostate Cells to Select Patients for Prostate Biopsy: Evidence, Utility and Cost-Benefit

By Nigel P. Murray, Eduardo Reyes, Nelson Orellana, Ricardo Dueñas, Cinthia Fuentealba and Leonardo Badinez

Submitted: March 2nd 2011Reviewed: July 25th 2011Published: December 2nd 2011

DOI: 10.5772/28697

Downloaded: 1689

© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Nigel P. Murray, Eduardo Reyes, Nelson Orellana, Ricardo Dueñas, Cinthia Fuentealba and Leonardo Badinez (December 2nd 2011). Future Aspects of Prostate Biopsy – The Use of Primary Circulating Prostate Cells to Select Patients for Prostate Biopsy: Evidence, Utility and Cost-Benefit, Prostate Biopsy, Nabil Kaddis Bissada, IntechOpen, DOI: 10.5772/28697. Available from:

chapter statistics

1689total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Technical Advices for Prostate Needle Biopsy Under Transrectal Ultrasound Guidance

By Makoto Ohori and Ayako Miyakawa

Related Book

First chapter

Percutaneous Muscle Biopsy: History, Methods and Acceptability

By Harnish P. Patel, Cyrus Cooper and Avan Aihie Sayer

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

More About Us